Vitro Biopharma
Biotechnology, 4621 Technology Drive, Golden, Colorado, 80403, United States, 11-50 Employees
Phone Number: 30********
Who is VITRO BIOPHARMA
Vitro Biopharma is an innovative biotechnology company focused on developing Wharton's jelly-derived cell therapies and targeting autoimmune diseases and inflammatory disorders. Our goal ...
Read More
-
Headquarters: 4621 Technology Drive, Golden, Colorado, 80403, United States
-
Date Founded: 1986
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 541714 |
Show More
Does something look wrong? Fix it. | View contact records from VITRO BIOPHARMA
Vitro Biopharma Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Vitro Biopharma
Answer: Vitro Biopharma's headquarters are located at 4621 Technology Drive, Golden, Colorado, 80403, United States
Answer: Vitro Biopharma's phone number is 30********
Answer: Vitro Biopharma's official website is https://vitrobiopharma.com
Answer: Vitro Biopharma's revenue is $1 Million to $5 Million
Answer: Vitro Biopharma's SIC: 2836
Answer: Vitro Biopharma's NAICS: 541714
Answer: Vitro Biopharma has 11-50 employees
Answer: Vitro Biopharma is in Biotechnology
Answer: Vitro Biopharma contact info: Phone number: 30******** Website: https://vitrobiopharma.com
Answer: Vitro Biopharma is an innovative biotechnology company focused on developing Wharton's jelly-derived cell therapies and targeting autoimmune diseases and inflammatory disorders. Our goal is to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market. AlloRx Stem Cell therapy is intended to be an off-the-shelf commercialized product that is stored frozen and available for on demand use. Our pipeline includes four core development programs. We intend to initiate our clinical trials for Long COVID and PTHS in late 2022 or 2023. In addition, we are also currently focused on our pre clinical development programs for MS and Lupus/SLE. Our research products include: a) Cell Culture Media -We offer various formulations of MSCs and primary cell cultures with numerous competitive advantages. b) Various Cell Lines -Our cell lines include Umbilical Cord Blood derived MSCs, Adipose derived MSCs, Fluorescent Labeled MSCs, Cancer Associated Fibroblasts (CAFs), and Differentiated MSCs c) Brain-Grow Technologies -Neurological and Inflammatory Biomarker Profiling and Nutraceutical Recovery Packages
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month